NCT06898632Completed
KidneyCare Cohort Study (KCC-S)
KidneyCare Cohort Study: Biologic Interrogation of Sarcopenia in Patients With Renal Cell Carcinoma
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This research study aims to learn how lifestyle factors (e.g., obesity) impact the risk of developing kidney cancer and impact survival after nephrectomy (removal of a kidney). The study team's long-term goals are to learn: 1) How to improve treatment success in future patients by tailoring therapies to each patient's unique biology; and 2) What future patients can do to improve their health after diagnosis. To this end, the study team will collect samples (such as blood and extra tissue from surgery) from patients and store and test these samples. The study team also asks patients about their health behaviors (e.g., diet and physical activity) and well-being before their diagnosis and afterwards by filling out questionnaires.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 161 (actual)
- First submitted
- 8 Sept 2022
- Start date
- 1 Mar 2021
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- University of Utah
- Diseases
- Kidney cancer
- NCT number
- NCT06898632
What you commit to
- Study type: Observational
- Participants enrolled: 161
- From 1 Mar 2021 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with only an MRI abdomen/pelvis within 4 months of surgery will be excluded
Other
- Does not consent to tissue collection
- Known biopsy-proven non-clear cell RCC
Who the study is looking for
- Renal Cell Cancer (RCC) stage I-IV
- Undergoing radical nephrectomy (entire kidney resection) or partial nephrectomy
- Patients with or without prior systemic therapy for renal cell carcinoma and \> 1 year from systemic therapy for other non-cutaneous malignancy
- Cytoreductive nephrectomy (nephrectomy in the setting of limited metastatic disease)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huntsman Cancer Institute Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.